Kiniksa Pharmaceuticals sees strong growth from Arcalyst, aided by Medicare redesign. Learn about 2025 sales outlook & ...

Pharmaceutically made cannabidiol targeting myocarditis did not increase cardiovascular events in at-risk patients, a ...

Autoinflammatory diseases predominantly affect young patients, many of whom may go on to become pregnant. For many ...

A document circulated to members of Congress misinterprets studies and cites debunked research, scientists say. It could ...

As much of the world moves on from the early chaos of the pandemic, a new COVID-19 variant is quietly making its way through ...

The HHS Department sent Congress a document defending a change to federal vaccine recommendations that cited unpublished or ...

US antivirals specialist Gilead Sciences’ Kite, unit today presented the latest results that demonstrate a 79% overall response rate (ORR) and 74% overall survival (OS) at six months follow-up, for ...

The safety of approved mRNA vaccines is well-established and, as with other vaccines, continues to be monitored by multiple ...